Pharmafile Logo

Aqurance

Aqurance consults Life Sciences industry to empower with digital solutions their salesforce, implementing top quality technology platforms, through its strategic partnerships. Founded in September 2011, with offices in Athens and Istanbul, is the fastest growing service provider for Life Sciences in South East Europe.
We believe that the future of Pharma is evidence-based. Our mission is to provide and implement effective tools that will help industry professionals make better and more effective decisions. We aim to facilitate Pharma managers in successfully overcoming budgetary and organizational challenges by using technology and data combined.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

MDNT

MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.

View Profile

Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Company Details

Egiou 1 & Figaleias Athens, Bilim Sokak Sun Plaza Kat: 13 Istanbul, Greece - Turkey, 14564 - 34398
+30 210 6200 206 - +90 212 366 02 40

 Latest Content from PMHub 

The Lucid Winter Summit 2016

Lucid Group put their skates on this year to celebrate an outstanding year’s performance at the Lucid Winter Summit at Somerset House, London.  Lucid Group enter their tenth year of...

How can the NHS deliver integrated care?

Sue Thomas and Paul Midgley, of Wilmington Healthcare, explain the changes needed to help the NHS provide a more holistic, joined up experience for patients

A Bitter Pill?

White Papers and Resources | December 14, 2016 | Inizio

The ideal route of admin isn’t clear cut in the global marketplace

2017: Medical education that improves value and outcomes for patients

In December’s Issue of PME, two of Lucid’s senior management team – Shula Sarner and Tanya Goodyear – consider how medical education will evolve in 2017.   They discuss industry...

How can pharma engage with NHS Vanguards?

Sue Thomas and Paul Midgley, of Wilmington Healthcare, explore the opportunities for pharma to help NHS vanguards develop new models of care.

Webinar: Become your customer’s chosen channel

Your customer now expects to access knowledge in any format and at any time that they desire. But how do you become the ever-present partner that they trust and value...

Understanding the chronic disease patient journey in emerging markets

White Papers and Resources | December 7, 2016 | Inizio

In this paper, we will explore the chronic disease patient journey in emerging markets and provide you with the insights you require to identify the key inflection points in these...

Infographic: Keeping tracking on track

White Papers and Resources | December 7, 2016 | Inizio

Our best practice approach to tracking studies.

Lucid Group kick off their Winter Festival

The start of December not only signalled the official calendar countdown to Christmas, but also marked the official launch of the Lucid Winter Festival, which culminates in the Winter Summit...

What does the Five Year Forward View mean for pharma?

Sue Thomas and Paul Midgley, of Wilmington Healthcare, assess how the Five Year Forward View (5YFV) is changing the NHS and how pharma can get involved in redesigning NHS services.